Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Appl Microbiol ; 128(5): 1355-1365, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31869477

RESUMEN

AIM: The study was aimed at purifying the active principle from Alpinia officinarum rhizomes responsible for inhibition of swarming motility of Pseudomonas aeruginosa and analysing the mechanism of action. METHODS AND RESULTS: The active compound from methanol extract of A. officinarum was purified by silica gel column chromatography followed by elution from Amberlite resin. The compound 1-(3,5-dihydroxyphenyl)-2-(methylamino)ethan-1-one, inhibited swarming motility at 12·5 µg ml-1 . This inhibition was independent of rhamnolipid production. Real-time PCR analysis showed significant down-regulation of virulence-associated genes including T3SS exoS, exoT and flagella master regulator fleQ. CONCLUSIONS: The compound from A. officinarum inhibited swarming motility and significantly down-regulated the expression of type III secretory system effector genes exoS and exoT and flagellar master regulator fleQ genes. SIGNIFICANCE AND IMPACT OF THE STUDY: The study identifies a potent swarming inhibitory compound from the common medicinal plant A. officinarum and reinstates the potential of plant-derived compounds in tackling virulence properties of pathogenic bacteria.


Asunto(s)
Alpinia/química , Antibacterianos/farmacología , Extractos Vegetales/farmacología , Pseudomonas aeruginosa/efectos de los fármacos , Antibacterianos/química , Regulación Bacteriana de la Expresión Génica/efectos de los fármacos , Locomoción/efectos de los fármacos , Extractos Vegetales/química , Plantas Medicinales/química , Pseudomonas aeruginosa/patogenicidad , Pseudomonas aeruginosa/fisiología , Rizoma/química , Sistemas de Secreción Tipo III/genética , Virulencia/genética
2.
Curr Drug Deliv ; 12(6): 709-16, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25772029

RESUMEN

Stable nano-formulation of Plumbagin nanoparticles from Plumbago zeylanica root extract was explored as a potential natural drug against prostate cancer. Size and morphology analysis by DLS, SEM and AFM revealed the average size of nanoparticles prepared was 100±50nm. In vitro cytotoxicity showed concentration and time dependent toxicity on prostate cancer cells. However, plumbagin crude extract found to be highly toxic to normal cells when compared to plumbagin nanoformulation, thus confirming nano plumbagin cytocompatibility with normal cells and dose dependent toxicity to prostate cells. In vitro hemolysis assay confirmed the blood biocompatibility of the plumbagin nanoparticles. In wound healing assay, plumbagin nanoparticles provided clues that it might play an important role in the anti-migration of prostate cancer cells. DNA fragmentation revealed that partial apoptosis induction by plumbagin nanoparticles could be expected as a potent anti-cancer effect towards prostate cancer.


Asunto(s)
Antineoplásicos Fitogénicos/administración & dosificación , Nanopartículas , Naftoquinonas/administración & dosificación , Neoplasias de la Próstata/tratamiento farmacológico , Animales , Antineoplásicos Fitogénicos/farmacología , Antineoplásicos Fitogénicos/toxicidad , Apoptosis/efectos de los fármacos , Línea Celular Tumoral , Fragmentación del ADN/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Humanos , Concentración de Iones de Hidrógeno , Masculino , Ratones , Células 3T3 NIH , Naftoquinonas/farmacología , Naftoquinonas/toxicidad , Tamaño de la Partícula , Extractos Vegetales/administración & dosificación , Extractos Vegetales/toxicidad , Plumbaginaceae/química , Neoplasias de la Próstata/patología , Factores de Tiempo
3.
Enzyme Microb Technol ; 52(2): 105-10, 2013 Feb 05.
Artículo en Inglés | MEDLINE | ID: mdl-23273279

RESUMEN

Integrated storage and pre-treatment (ISP) combines biopreservation of moist material under airtight conditions and pre-treatment. Moist wheat straw was inoculated with the biocontrol yeast Wickerhamomyces anomalus, the xylan degrading yeast Scheffersomyces stipitis or a co-culture of both. The samples and non-inoculated controls were stored at 4 or 15 °C. The non-inoculated controls were heavily contaminated with moulds, in contrast to the samples inoculated with W. anomalus or S. stipitis. These two yeasts were able to grow on wheat straw as sole source of nutrients. When ethanol was produced from moist wheat straw stored for four weeks at 4 °C with S. stipitis, an up to 40% enhanced yield (final yield 0.15 g ethanol per g straw dry weight) was obtained compared to a dry sample (0.107 g/g). In all other moist samples, stored for four weeks at 4 °C or 15 °C, 6-35% higher yields were obtained. Thus, energy efficient bio-preservation can improve the pre-treatment efficiency for lignocellulose biomass, which is a critical bottleneck in its conversion to biofuels.


Asunto(s)
Biocombustibles , Debaryomyces/metabolismo , Etanol/metabolismo , Pichia/metabolismo , Tallos de la Planta/metabolismo , Preservación Biológica/métodos , Triticum/metabolismo , Biomasa , Técnicas de Cocultivo , Fermentación , Proteínas Fúngicas/metabolismo , Calor , Humedad , Lignina/metabolismo , Tallos de la Planta/efectos de los fármacos , Tallos de la Planta/microbiología , Saccharomyces cerevisiae/metabolismo , Ácidos Sulfúricos/farmacología , Temperatura , Triticum/efectos de los fármacos , Triticum/microbiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA